Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

2.02
-0.3400-14.41%
Pre-market: 2.100.0800+3.96%06:04 EDT
Volume:2.97M
Turnover:6.20M
Market Cap:187.20M
PE:-13.97
High:2.38
Open:2.38
Low:1.89
Close:2.36
52wk High:10.38
52wk Low:1.89
Shares:92.67M
Float Shares:91.12M
Volume Ratio:3.13
T/O Rate:3.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1446
EPS(LYR):-0.5438
ROE:-12.80%
ROA:-9.70%
PB:1.66
PE(LYR):-3.71

Loading ...

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Nominates Gautam Patel and Adrian Senderowicz as Independent Directors

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Urges Stockholders to Reject Pvg Asset Management and Patrick S. Adams Control Attempt

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Files Preliminary Proxy Statement with SEC on July 31, 2026

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Christopher Missling and Steffen Thomas to Leave Board After 2026 Annual Meeting

THOMSON REUTERS
·
Aug 03

Promising Penny Stocks To Consider In August 2026

Simply Wall St.
·
Aug 03

Anavex Urges Vote for Its Six Director Nominees as PVG Group Seeks Board Seats Ahead of Annual Meeting

Reuters
·
Aug 01

Werewolf Therapeutics Posts Q2 Profit on Jazz Asset Sale

Reuters
·
Jul 31

Tenax Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Jul 31

Anavex Life Sciences Corp Reports Results for the Quarter Ended March 31 - Earnings Summary

Reuters
·
Jul 31

Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) Estimate

Benzinga Earnings
·
Jul 30

Disc Medicine Posts Smaller-than-expected Q2 Net Loss

Reuters
·
Jul 30

Anavex Life Sciences Q2 Net Loss Narrows on Lower R&D Costs

Reuters
·
Jul 30

Anavex Life Sciences Reports Preliminary Q2 Net Loss Of $0.06 Per Share vs. $0.13 A Year Ago; $127.4M Cash Funds Operations Into Mid-To-Late Fiscal 2028

Benzinga Earnings
·
Jul 30

Anavex Life Sciences Q3 EPS USD -0.06

THOMSON REUTERS
·
Jul 30

Anavex Life Sciences Q3 Net Income USD -5.3 Million

THOMSON REUTERS
·
Jul 30

Press Release: Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Jul 30

Anavex Submits NASDAQ Compliance Plan After Late Filing of Quarterly Report

Reuters
·
Jul 20

Anavex Life Sciences Sets 2026 Annual Shareholder Meeting

Reuters
·
Jun 26

U.S. Earnings Preview: Before Market Open June 16

Dow Jones
·
Jun 16